Eosinopenia in Patients With Typhoid Fever: A Case-Control Study.

eosinopenia leukopenia salmonella typhi typhoid fever

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
10 Sep 2020
Historique:
entrez: 16 10 2020
pubmed: 17 10 2020
medline: 17 10 2020
Statut: epublish

Résumé

Background and objectives Salmonella typhi is involved in one of the most prevalent infectious diseases of South East Asia, typhoid fever, but diagnostic tests cannot be performed regularly in developing countries. The objective of the study is to determine the association of eosinopenia with culture or serology-proven typhoid fever in patients, to determine the association of leukopenia with culture or serology-proven typhoid fever in patients and to determine independent predictors of eosinopenia. Methods This case-control study, done at Fauji Foundation Hospital, Pakistan, included patients with symptoms suggestive of typhoid fever, culture, or serology positive for typhoid fever and excluded patients who had been previously diagnosed with malaria and dengue hemorrhagic fever. After flagging cultures and serology, the records were viewed for leukocyte counts. Data, including age, gender, and clinical symptoms, were also recorded for analysis. Results Out of 200 participants, 59 participants with diagnosed typhoid fever had eosinopenia. There were 29 participants who had been diagnosed with typhoid fever via culture or serology and had leukopenia. Eosinopenia and leukopenia were more likely to be present in patients with a diagnosis of typhoid (OR: 9.60, 20.00). The independent predictors for eosinopenia were DOT enzyme immunoassay (DOT EIA) positive for Salmonella typhi, culture positive for Salmonella typhi and leukopenia (p<0.05). Conclusion The presence of eosinopenia and features or serology suggestive of typhoid would most likely be associated with cultures being positive and, therefore, might provide an efficient means to begin treatment.

Identifiants

pubmed: 33062482
doi: 10.7759/cureus.10359
pmc: PMC7549842
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10359

Informations de copyright

Copyright © 2020, Ishaq et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Elife. 2014 Jun 05;3:
pubmed: 24902583
Acta Trop. 1998 May;69(2):165-73
pubmed: 9588236
Cureus. 2017 Dec 6;9(12):e1910
pubmed: 29441245
Indian Pediatr. 2019 Dec 15;56(12):1033-1036
pubmed: 31884434
Am J Epidemiol. 2004 Jul 1;160(1):46-50
pubmed: 15229116
Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1523-1532
pubmed: 31119578
Am J Trop Med Hyg. 2019 Jan;100(1):43-46
pubmed: 30426919
Malawi Med J. 2019 Sep;31(3):184-192
pubmed: 31839887
Lancet Infect Dis. 2018 Dec;18(12):1368-1376
pubmed: 30507460
Mymensingh Med J. 2009 Jan;18(1):13-7
pubmed: 19182742
Infect Dis (Lond). 2018 Mar;50(3):163-174
pubmed: 29070003
Mediterr J Hematol Infect Dis. 2015 Mar 01;7(1):e2015021
pubmed: 25745548
PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376
pubmed: 28241011
PLoS One. 2017 Jun 23;12(6):e0179814
pubmed: 28644847
Trop Doct. 2018 Apr;48(2):124-127
pubmed: 28959915
J Travel Med. 2018 Jan 1;25(1):
pubmed: 30060197
BMC Med. 2020 Jan 3;18(1):1
pubmed: 31898501
BMC Res Notes. 2018 Aug 22;11(1):605
pubmed: 30134970

Auteurs

Uzma Ishaq (U)

Hematology and Medical Oncology, Fauji Foundation Hospital, Rawalpindi, PAK.

Jahanzeb Malik (J)

Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.

Maliha Asif (M)

Pathology, Rahber Medical and Dental College, Lahore, PAK.

Hina Zaib (H)

Hematology, Ali Medical Center, Rawalpindi, PAK.

Iqbal Haider (I)

Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.

Tayyaba Zahid (T)

Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.

Rana Abdul Sattar (R)

Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.

Umar Ikram (U)

Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.

Classifications MeSH